
Chemical and Pharmaceutical Bulletin p. 202 - 211 (1992)
Update date:2022-08-05
Topics:
Sakaguchi
Nishino
Ogawa
Iwanaga
Yasuda
Kato
Ito
Novel N-[[2-(dialkylamino)ethoxy]benzyl]benzamide derivatives (II-1-51), derived from the structural modification of metoclopramide (1), were synthesized and examined for their pharmacological activities. Among them, N-[4-[2-(dimethylamino)ethoxy]benzyl]-3,4-dimethoxybenzamide (II-34) which exhibited well balanced gastrointestinal prokinetic and antiemetic activities was selected as a new type of gastrointestinal prokinetic agent.
View MoreTaimai Sanluck Pharmaceutical Co.,Ltd
Contact:86-592-7662921
Address:8D,No.186,Huarong Road,Huli,Xiamen,China
RongCheng Tianyu Technology Co.,Ltd.
Contact:86-631-7519595
Address:220Ping Donghai Road RongChengCity,ShangDong Province China
Oren Hydrocarbons (Qingdao) Co., Ltd.
Contact:+86-532-68607667-801
Address:Room 3 # 302, No.9 Qingyun Road, Qingdao, China
Allright GC (Jinan) Biotechnology Ltd.
website:https://www.argcbiotech.com/
Contact:86-18405413579-
Address: No.27566 of Jingshiroad, Huaiyin District, Jinan City(250011), Shandong Province, China.
Shanghai Standard Biotech Co., Ltd.
Contact:+86-18502101150
Address:Room 103, Building 2nd, NO.720, Cailun Road , Pudong District, Shanghai, China
Doi:10.1055/s-2002-34384
(2002)Doi:10.1080/00397919808005968
(1998)Doi:10.1021/jm00281a019
(1972)Doi:10.1016/j.ejmech.2016.07.024
(2016)Doi:10.1002/ardp.202000052
(2020)Doi:10.1039/P19730000316
(1973)